Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-04

AUTHORS

Suzanne McMullen, Lisa M. Hess, Edward S. Kim, Benjamin Levy, Mohamed Mohamed, David Waterhouse, Antoinette Wozniak, Sarah Goring, Kerstin Müller, Catherine Muehlenbein, Himani Aggarwal, Yajun Zhu, Ana B. Oton, Jennifer L. Ersek, Katherine B. Winfree

ABSTRACT

INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT. METHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics. RESULTS: Interviewed patients (n = 10) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n = 77) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT. CONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT. More... »

PAGES

223-233

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3

DOI

http://dx.doi.org/10.1007/s40271-018-0327-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106255770

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30128728


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McMullen", 
        "givenName": "Suzanne", 
        "id": "sg:person.011426620154.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011426620154.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hess", 
        "givenName": "Lisa M.", 
        "id": "sg:person.01006106475.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006106475.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "Levine Cancer Institute, Atrium Health, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Edward S.", 
        "id": "sg:person.014001775337.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014001775337.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416167.3", 
          "name": [
            "Mount Sinai Health Systems, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy", 
        "givenName": "Benjamin", 
        "id": "sg:person.01076771225.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076771225.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cone Health", 
          "id": "https://www.grid.ac/institutes/grid.416125.5", 
          "name": [
            "Cone Health, Greensboro, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohamed", 
        "givenName": "Mohamed", 
        "id": "sg:person.012164362407.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012164362407.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Hematology Care", 
          "id": "https://www.grid.ac/institutes/grid.492834.0", 
          "name": [
            "Oncology Hematology Care (OHC), Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Waterhouse", 
        "givenName": "David", 
        "id": "sg:person.01317373531.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317373531.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Karmanos Cancer Institute, Detroit, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wozniak", 
        "givenName": "Antoinette", 
        "id": "sg:person.010560436717.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010560436717.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goring", 
        "givenName": "Sarah", 
        "id": "sg:person.015274701305.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015274701305.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "M\u00fcller", 
        "givenName": "Kerstin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muehlenbein", 
        "givenName": "Catherine", 
        "id": "sg:person.0605751225.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605751225.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aggarwal", 
        "givenName": "Himani", 
        "id": "sg:person.010370103253.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010370103253.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Yajun", 
        "id": "sg:person.01347757475.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347757475.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oton", 
        "givenName": "Ana B.", 
        "id": "sg:person.01177655333.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177655333.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "Levine Cancer Institute, Atrium Health, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ersek", 
        "givenName": "Jennifer L.", 
        "id": "sg:person.01017444367.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017444367.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Winfree", 
        "givenName": "Katherine B.", 
        "id": "sg:person.01050057502.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050057502.62"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.13-s1-28", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003695569"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70339-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014529972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2354.2012.01346.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018763292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.19.1114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020749774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2013.03.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026254798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2013.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031003699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ageing/afn226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035714657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.19.1068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040602317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.47.1102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041282863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e3181fff142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050770715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0738-3991(01)00155-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052263210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0000000000000207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053640246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0025-6196(11)60735-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054591557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s138863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091926310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-018-3986-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100404015", 
          "https://doi.org/10.1186/s12885-018-3986-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT.\nMETHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics.\nRESULTS: Interviewed patients (n\u2009=\u200910) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n\u2009=\u200977) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT.\nCONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40271-018-0327-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1038760", 
        "issn": [
          "1178-1653", 
          "1178-1661"
        ], 
        "name": "The Patient - Patient-Centered Outcomes Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy", 
    "pagination": "223-233", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6fd0d679787b21e77840c4883428a017c985b4d85e79f8c6f87bbb540ed2186a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30128728"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101309314"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40271-018-0327-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106255770"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40271-018-0327-3", 
      "https://app.dimensions.ai/details/publication/pub.1106255770"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78953_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40271-018-0327-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40271-018-0327-3 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N7a674d8642544de99e416cea8a4a4082
4 schema:citation sg:pub.10.1186/s12885-018-3986-5
5 https://doi.org/10.1016/j.lungcan.2013.03.008
6 https://doi.org/10.1016/s0025-6196(11)60735-0
7 https://doi.org/10.1016/s0738-3991(01)00155-0
8 https://doi.org/10.1016/s1470-2045(11)70339-4
9 https://doi.org/10.1053/j.seminoncol.2013.12.013
10 https://doi.org/10.1093/ageing/afn226
11 https://doi.org/10.1097/jto.0000000000000207
12 https://doi.org/10.1097/jto.0b013e3181fff142
13 https://doi.org/10.1111/j.1365-2354.2012.01346.x
14 https://doi.org/10.1200/jco.2012.47.1102
15 https://doi.org/10.1634/theoncologist.13-s1-28
16 https://doi.org/10.2147/ppa.s138863
17 https://doi.org/10.3747/co.19.1068
18 https://doi.org/10.3747/co.19.1114
19 schema:datePublished 2019-04
20 schema:datePublishedReg 2019-04-01
21 schema:description INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT. METHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics. RESULTS: Interviewed patients (n = 10) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n = 77) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT. CONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree true
25 schema:isPartOf N3a53df018cad4e899db015d7cd46d09f
26 N3e603bcb7af64f8badfe40a70cd4e126
27 sg:journal.1038760
28 schema:name Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
29 schema:pagination 223-233
30 schema:productId N5d4072a3ee934c078b45a5237c58a1b4
31 N77e42adf1280400bae2edd6db26e6687
32 N7d306987a35840b480995756455c3643
33 N9d493d3262684769a36596c96204cb09
34 Nc5166c5041c04f5b81a23d1abd4b1bed
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106255770
36 https://doi.org/10.1007/s40271-018-0327-3
37 schema:sdDatePublished 2019-04-11T13:19
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N3618d431b7a44dfba726820f4c3618d6
40 schema:url https://link.springer.com/10.1007%2Fs40271-018-0327-3
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N0856c889031f4cfeaeca93c74b10d41c rdf:first sg:person.01177655333.39
45 rdf:rest Nfbbc3c1fdbd94fa9ae0c894fbcc72453
46 N097d2f649d3e490f851098e42f99081b rdf:first sg:person.010560436717.26
47 rdf:rest N182d5b09aaf74e3b923595861c182efe
48 N1062f73ed8114072ac32e7f3ffffef60 rdf:first sg:person.01347757475.25
49 rdf:rest N0856c889031f4cfeaeca93c74b10d41c
50 N182d5b09aaf74e3b923595861c182efe rdf:first sg:person.015274701305.67
51 rdf:rest N8d4c4d58e0d540ceb0f4ea63729dc616
52 N26838359fae14467a1ee98feff7bc1b6 rdf:first sg:person.010370103253.14
53 rdf:rest N1062f73ed8114072ac32e7f3ffffef60
54 N3618d431b7a44dfba726820f4c3618d6 schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 N3a53df018cad4e899db015d7cd46d09f schema:issueNumber 2
57 rdf:type schema:PublicationIssue
58 N3e28fc9ca12945bea477766202c71518 rdf:first sg:person.01076771225.72
59 rdf:rest N44604dcd76a141069966683d98b682a2
60 N3e603bcb7af64f8badfe40a70cd4e126 schema:volumeNumber 12
61 rdf:type schema:PublicationVolume
62 N44604dcd76a141069966683d98b682a2 rdf:first sg:person.012164362407.11
63 rdf:rest N5ab5f96bf24d4447956add05fb9f899f
64 N4782503b5eca4986a451af132e63db4c schema:affiliation Nea4636caf38f4fe88be13c1ea5465625
65 schema:familyName Müller
66 schema:givenName Kerstin
67 rdf:type schema:Person
68 N5ab5f96bf24d4447956add05fb9f899f rdf:first sg:person.01317373531.42
69 rdf:rest N097d2f649d3e490f851098e42f99081b
70 N5d4072a3ee934c078b45a5237c58a1b4 schema:name dimensions_id
71 schema:value pub.1106255770
72 rdf:type schema:PropertyValue
73 N77e42adf1280400bae2edd6db26e6687 schema:name pubmed_id
74 schema:value 30128728
75 rdf:type schema:PropertyValue
76 N7a674d8642544de99e416cea8a4a4082 rdf:first sg:person.011426620154.88
77 rdf:rest N8808a6911f324ef3beee47a776cadb11
78 N7d306987a35840b480995756455c3643 schema:name readcube_id
79 schema:value 6fd0d679787b21e77840c4883428a017c985b4d85e79f8c6f87bbb540ed2186a
80 rdf:type schema:PropertyValue
81 N84018f3c23784a3a8458d18da6a08462 rdf:first sg:person.014001775337.24
82 rdf:rest N3e28fc9ca12945bea477766202c71518
83 N86139b1656c74b0c91f283700922e9bb schema:name ICON Plc, Vancouver, BC, Canada
84 rdf:type schema:Organization
85 N8617f706b4284193b3ad0c80cacac0fa rdf:first sg:person.0605751225.25
86 rdf:rest N26838359fae14467a1ee98feff7bc1b6
87 N8808a6911f324ef3beee47a776cadb11 rdf:first sg:person.01006106475.67
88 rdf:rest N84018f3c23784a3a8458d18da6a08462
89 N88e60787fdd141d68b8e53ad97094a43 schema:name ICON Plc, Vancouver, BC, Canada
90 rdf:type schema:Organization
91 N8d4c4d58e0d540ceb0f4ea63729dc616 rdf:first N4782503b5eca4986a451af132e63db4c
92 rdf:rest N8617f706b4284193b3ad0c80cacac0fa
93 N9d493d3262684769a36596c96204cb09 schema:name nlm_unique_id
94 schema:value 101309314
95 rdf:type schema:PropertyValue
96 Nc5166c5041c04f5b81a23d1abd4b1bed schema:name doi
97 schema:value 10.1007/s40271-018-0327-3
98 rdf:type schema:PropertyValue
99 Ne22b7870612e4ba1abd80e9a243337a5 rdf:first sg:person.01050057502.62
100 rdf:rest rdf:nil
101 Nea4636caf38f4fe88be13c1ea5465625 schema:name ICON Plc, Vancouver, BC, Canada
102 rdf:type schema:Organization
103 Nfbbc3c1fdbd94fa9ae0c894fbcc72453 rdf:first sg:person.01017444367.34
104 rdf:rest Ne22b7870612e4ba1abd80e9a243337a5
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
109 schema:name Oncology and Carcinogenesis
110 rdf:type schema:DefinedTerm
111 sg:journal.1038760 schema:issn 1178-1653
112 1178-1661
113 schema:name The Patient - Patient-Centered Outcomes Research
114 rdf:type schema:Periodical
115 sg:person.01006106475.67 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
116 schema:familyName Hess
117 schema:givenName Lisa M.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006106475.67
119 rdf:type schema:Person
120 sg:person.01017444367.34 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
121 schema:familyName Ersek
122 schema:givenName Jennifer L.
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017444367.34
124 rdf:type schema:Person
125 sg:person.010370103253.14 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
126 schema:familyName Aggarwal
127 schema:givenName Himani
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010370103253.14
129 rdf:type schema:Person
130 sg:person.01050057502.62 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
131 schema:familyName Winfree
132 schema:givenName Katherine B.
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050057502.62
134 rdf:type schema:Person
135 sg:person.010560436717.26 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
136 schema:familyName Wozniak
137 schema:givenName Antoinette
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010560436717.26
139 rdf:type schema:Person
140 sg:person.01076771225.72 schema:affiliation https://www.grid.ac/institutes/grid.416167.3
141 schema:familyName Levy
142 schema:givenName Benjamin
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076771225.72
144 rdf:type schema:Person
145 sg:person.011426620154.88 schema:affiliation N86139b1656c74b0c91f283700922e9bb
146 schema:familyName McMullen
147 schema:givenName Suzanne
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011426620154.88
149 rdf:type schema:Person
150 sg:person.01177655333.39 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
151 schema:familyName Oton
152 schema:givenName Ana B.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177655333.39
154 rdf:type schema:Person
155 sg:person.012164362407.11 schema:affiliation https://www.grid.ac/institutes/grid.416125.5
156 schema:familyName Mohamed
157 schema:givenName Mohamed
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012164362407.11
159 rdf:type schema:Person
160 sg:person.01317373531.42 schema:affiliation https://www.grid.ac/institutes/grid.492834.0
161 schema:familyName Waterhouse
162 schema:givenName David
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317373531.42
164 rdf:type schema:Person
165 sg:person.01347757475.25 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
166 schema:familyName Zhu
167 schema:givenName Yajun
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347757475.25
169 rdf:type schema:Person
170 sg:person.014001775337.24 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
171 schema:familyName Kim
172 schema:givenName Edward S.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014001775337.24
174 rdf:type schema:Person
175 sg:person.015274701305.67 schema:affiliation N88e60787fdd141d68b8e53ad97094a43
176 schema:familyName Goring
177 schema:givenName Sarah
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015274701305.67
179 rdf:type schema:Person
180 sg:person.0605751225.25 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
181 schema:familyName Muehlenbein
182 schema:givenName Catherine
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605751225.25
184 rdf:type schema:Person
185 sg:pub.10.1186/s12885-018-3986-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100404015
186 https://doi.org/10.1186/s12885-018-3986-5
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.lungcan.2013.03.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026254798
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/s0025-6196(11)60735-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054591557
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/s0738-3991(01)00155-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052263210
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/s1470-2045(11)70339-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014529972
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1053/j.seminoncol.2013.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031003699
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1093/ageing/afn226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035714657
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1097/jto.0000000000000207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053640246
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1097/jto.0b013e3181fff142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050770715
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1111/j.1365-2354.2012.01346.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018763292
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1200/jco.2012.47.1102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041282863
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1634/theoncologist.13-s1-28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003695569
209 rdf:type schema:CreativeWork
210 https://doi.org/10.2147/ppa.s138863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091926310
211 rdf:type schema:CreativeWork
212 https://doi.org/10.3747/co.19.1068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040602317
213 rdf:type schema:CreativeWork
214 https://doi.org/10.3747/co.19.1114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020749774
215 rdf:type schema:CreativeWork
216 https://www.grid.ac/institutes/grid.254444.7 schema:alternateName Wayne State University
217 schema:name Karmanos Cancer Institute, Detroit, MI, USA
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.416125.5 schema:alternateName Cone Health
220 schema:name Cone Health, Greensboro, NC, USA
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.416167.3 schema:alternateName Mount Sinai Hospital
223 schema:name Mount Sinai Health Systems, New York, NY, USA
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.417540.3 schema:alternateName Eli Lilly (United States)
226 schema:name Eli Lilly and Company, Indianapolis, IN, USA
227 rdf:type schema:Organization
228 https://www.grid.ac/institutes/grid.468189.a schema:alternateName Levine Cancer Institute
229 schema:name Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.492834.0 schema:alternateName Oncology Hematology Care
232 schema:name Oncology Hematology Care (OHC), Cincinnati, OH, USA
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...